Shares of the largest used car dealer in the US, CarMax (KMX.US) came under supply-side pressure today amid weak financial results for the fiscal quarter ended November 30, 2022:
Earnings per share: $0.24 vs. $0.70 expected and $1.63 in 2021
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appNet income: $37.6 million vs. $264.9 million in Q4 2021
Revenue: $6.51 billion vs. $7.16 billion forecast
Used car sales fell 22.9% y/y vs. 16.9% decline according to FactSet
Average sales rose 1.9% to $28,530.
U.S. consumers are tipping on high car prices, especially in the electric car market. According to Cars.com, the average price of used Rivian cars is 132% of new models. The premium is possible mainly because of the long waiting time for new models. The average price of Lucid cars was about 92% of the average price of a new model. Carmax also said in a press release that it is beginning to lose it's share in the cars market although it still gained it on an annual basis. The previous quarter's results also fell short of analysts' expectations. The in the media commentary informed that macro factors hitting demand and situation will persist in the next quarter as inflationary pressures and rising interest rates weigh on consumer opportunities and sentiment. CarMax announced the suspension of its share repurchase program deepening the decline in shareholders sentiment.
Carmax (KMX.US) shares, D1 interval. The rebound after the downward gap was stopped at the levels of previous lows, at $55 per share. The stock clearly respects resistance in the form of the 200-session moving average (red line). Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
